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Abstract: Interferon gamma (IFNG) plays a key role during Mycobacterium tuberculosis (Mtb) infection,
and several polymorphisms located in its gene are associated with risk of tuberculosis in diverse
populations. Nevertheless, the genetic resistance/susceptibility to tuberculosis in Argentina is unknown.
The IFNG rs1861494 polymorphism (G→A) was reported to alter the binding of transcription factors
to this region, influencing IFNG production. Using a case-control study, we found an association
between the AA and AG genotypes and tuberculosis resistance (AA vs. GG: odds ratio (OR) = 0.235,
p-value = 0.012; AG vs. GG: OR = 0.303, p-value = 0.044; AA vs. AG: OR = 0.776, p-value = 0.427;
AA + AG vs. GG: OR = 0.270, p-value = 0.022). Moreover, Mtb-antigen stimulated peripheral blood
mononuclear cells (PBMCs) from healthy donors and AA carriers secreted the highest amounts of
IFNG in culture supernatants (p-value = 0.034) and presented the greatest percentage of CD4+IFNG+
lymphocytes (p-value = 0.035), in comparison with GG carriers. No association between the
polymorphism and clinical parameters of tuberculosis severity was detected. However, our findings
indicate that the rs1861494 single nucleotide polymorphism (SNP) could be considered as a biomarker
of tuberculosis resistance in the Argentinean population.
Keywords: Interferon gamma; mycobacterium tuberculosis; single nucleotide polymorphism;
rs1861494; tuberculosis
1. Introduction
Mycobacterium tuberculosis (Mtb) infects 2 billon people around the world, causing 10.3 million
new active tuberculosis cases and 1.8 million deaths annually [1]. In Argentina, last reports estimated
10,733 cases of tuberculosis, clearly demonstrating the importance of this disease [2]. However, most
individuals exposed to Mtb do not develop active tuberculosis, suggesting that both host genetic
factors and environmental causes might influence the susceptibility to the disease [3].
Efficient activation of cellular immunity is important to establish a protective immune response
against intracellular pathogens like Mtb, where cytokines play an essential role in the process [4,5].
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The immune response elicited after Mtb infection is critically dependent on CD4+ T cells. In particular,
T helper (Th) 1 cells play a crucial function in granuloma formation and clearance of Mtb [6,7].
Interferon gamma (IFNG) is a key type 1 cytokine produced primarily by natural killer cells
and Th1 lymphocytes, is a crucial mediator of macrophages activation and controlling Mtb infection.
Especially, IFNG has been shown to activate downstream antimicrobial effector pathways, including
inducible nitric oxide synthase (iNOS), IFNG-inducible GTPases, phagosomal maturation and
acidification, autophagy and vitamin D receptor signaling [8–11]. The degree of reduction in IFNG
production by peripheral blood mononuclear cells (PBMC) is a marker of disease severity in patients
with tuberculosis (TB). Besides, IFNG secretion is lower in patients with the most severe manifestation
of tuberculosis [12,13]. Moreover, detection of IFNG produced by T cells is the most widely used
method for monitoring immune responses following infection or vaccination [14].
It is expected that some genetic variants of main cytokines that operate during host-pathogen
interaction would be associated with a higher resistance or susceptibility to Mtb infection. Actually,
family-based association studies in leprosy and tuberculosis evidenced the genetic influence in the
susceptibility to infectious diseases [15]. Indeed, inherited defects of the Interleukin 12 (IL12)/IFNG
pathway are related to Mendelian susceptibility to Mycobacterial disease, a disorder characterized by
disseminated mycobacterial infections, denoting the importance of the IL12/IFNG pathway, as well as
the relevance of the host genetic background [16].
Single nucleotide polymorphisms (SNPs) are believed to be the main source of variability among
humans, especially when they influence gene expression or function depending on their location in
the DNA sequence. Moreover, since SNPs are relatively easy to be detected, they are considered as
one of the best biological markers in association or case-control studies [15]. It has been described
previously that polymorphisms in genes related to cytokine expression could affect the susceptibility
to different diseases [17–22]. Cytokines play a crucial role in the immune response against several
infectious diseases. Therefore, cytokine genes are important targets to be studied. For example,
there are many SNPs in cytokine genes reported as possible causes of resistance/susceptibility to
tuberculosis. Zhang et al. showed that a functional SNP in the promoter gene encoding Interleukin
6 (IL6) is associated with susceptibility to tuberculosis [23]. Furthermore, among others, SNPs in
Interleukin 1β (IL1B), IL12, IFNG, Interleukin 10 (IL10) and Tumor Necrosis Factor α (TNFα) genes
were described in relation with risk to tuberculosis disease [24–26]. Recently we have demonstrated
that the Interleukin 17A (IL17A) rs2275913 SNP is associated with protection to tuberculosis but related
to higher disease severity in Argentina [27].
The IFNG rs1861494 SNP (G→A) is located within a conserved regulatory region of the third
intron of the IFNG gene (position +2019). It was evidenced that this SNP introduces a new potential
CpG methylation site, resulting in altered transcription factors binding to this region, which might
have a functional consequence on IFNG expression. Actually, it was reported the association of the A
allele with higher levels of IFNG, both in plasma and in stimulated T lymphocytes [28,29]. Until now,
there are no studies in the Argentinean population analyzing the association between an IFNG SNP
and tuberculosis.
Thus, it is important to investigate the role of potential genetic variations in molecules of the
immune system that participate in the development of the disease in Argentina. In this work,
we investigated the potential association of the IFNG rs1861494 SNP and active disease. We also
evaluated the functional relevance of this SNP during the immune response of the host against Mtb
and analyzed its impact on clinical parameters of the disease severity.
2. Materials and Methods
Human immunodeficiency virus (HIV)-uninfected patients with active tuberculosis were
diagnosed at the Muñiz Hospital (Buenos Aires, Argentina), based on clinical and radiological data,
together with the identification of acid-fast bacilli in sputum and isolation of Mtb in culture. Patients
recruited were individuals vaccinated with Bacille Calmette Guerin M. bovis (BCG) that had no
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underlying diseases (cancer, diabetes, chronic obstructive pulmonary disease, immune-related diseases
and others) at the time the sample was obtained and had received less than 1 week of anti-tuberculosis
therapy. Healthy donors (HD) recruited were individuals vaccinated with BCG who lack history
of tuberculosis, and with no underlying diseases (cancer, diabetes, immune-related diseases and
others) or any pharmacological treatment at the time of recruitment. All HD were tested using
the QuantiFERON-TB© Gold In-Tube test (QFT-Qiagen, Hilden, Germany), and only QFT negative
individuals were included in this group. Subjects with latent tuberculosis (positive QFT) were excluded
from the study. Remarkably, more than 85% of individuals from the HD population were subjects
exposed to Mtb but not infected with the pathogen (negative QFT). These individuals were recruited
from families who had at least one patient living in the same household, having high probability
of repeated exposure, making this population an appropriate control for the case-control study [15].
All participants provided a written, informed consent for the collection of samples and subsequent
analysis. All methods were carried out in accordance with in accordance with the Declaration of
Helsinki. The protocols conducted were approved by the Ethical Committee of the Muñiz Hospital
(protocol code 295, year of approval 2011; and protocol code 296, year of approval 2013). All the
individuals participating in this study were over 18 years old.
Genomic DNA (gDNA) was extracted from whole blood samples using the Quick-gDNATM
Blood MiniPrep (Zymo Research, Irvine, CA, USA) according to the manufacturer’s instructions.
Amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) was used for the
rs1861494 SNP genotyping. The ARMS-PCR is based on allele specific amplification of desired fragment
using primers corresponding to each allelic variant [30]. The sequences of the primers used were: Allele
A specific reverse 5′-AAGTAGGTGAGGAAGAAGCA-3′; Allele G specific reverse 5′-AAGTAGGTGAG
GAAGAAGCA-3′; Common forward 5′-CCTTGGTGGCTGAGTTGG-3′. As an internal control, human
growth hormone (HGH) gene primers (Forward 5′-GCCTTCCCAACCATTCCCTTA-3′, Reverse 5′-TC
ACGGATTTCTGTTGTGTTTC-3′) were included in every PCR mix to verify successful amplification
(440 bp amplicon). The amplification was performed in a Multigene Gradient thermal cycler
(LabNet International, Edison, NJ, USA). The conditions included initial denaturation (94 ◦C for
5 min) following a 35 times cycles of denaturation at 94 ◦C for 30 s, annealing at 62 ◦C for 50 s and
extension at 72 ◦C for 45 s each cycle; and final extension at 72 ◦C for 5 min. The rs1861494 genotypes
were assessed from the presence/absence of PCR amplicon (168 bp), corresponding to the specific allele
(A/G) on 1.5% agarose gel stained with SYBR Green (Thermo Fisher Scientific, Waltham, MA, USA).
All genotypes of the rs1861494 SNP were confirmed by direct sequencing of the amplified IFNG gene
fragment by Sanger method, and a 100% concordance was obtained among the results obtained from
ARMS-PCR and DNA sequencing (Supplementary Figure S1).
Plasma samples were collected by blood centrifugation. In vitro stimulation of cells throughout
the study was performed with a cell lysate from the virulent Mtb H37Rv strain (Mtb-Ag, M. tuberculosis,
Strain H37Rv, whole cell lysate, NR-14822) of the Biodefense and Emerging Infections Research
Resources Repository, National Institute of Allergy and Infectious Diseases, National Institutes of
Health (Manassas, VA, USA). Peripheral blood mononuclear cells were isolated by centrifugation over
Ficoll-Hypaque and cultured (1 × 106 cells/mL) ± Mtb-Ag (10 µg/mL) with RPMI 1640 medium
(Gibco, Thermo Fisher) supplemented with 1% L-glutamine, 1% penicillin/ streptomycin, and 10%
human serum (Sigma-Aldrich, Saint Louis, MO, USA) for five days. Plasma and supernatant samples
were stored at −80 ◦C until IFNG determination by ELISA (BioLegend, San Diego, CA, USA),
following manufacturer’s instructions. For intracellular cytokine staining, monensin (1 µL/mL;
Sigma-Aldrich) was added for the last 5 h of culture, and then cells were stained with specific
fluorophore-conjugated antibodies against CD4 (BioLegend), and IFNG (eBioscience, Thermo Fisher),
prior cell permeabilization with 0.5% saponin.
The genotype and allele frequencies were obtained by direct counting. Hardy–Weinberg
(HW) equilibrium was tested between cases and controls separately (X2 test). Comparisons of the
distributions of the allele and genotype frequencies between case and control were performed using the
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X2 test with Yates correction or Fisher exact test. The association level between the rs1861494 genotypes
and the case/control condition was estimated as an odds ratio (OR), with a 95% confidence interval
(95% CI), calculated by logistic regression after adjusting for confounding variables (age/ethnicity/sex).
An a priori statistical analysis to determine the final sample size was performed with an initial
population of 50 HD and 50 TB. The sample size estimation to get a test power of 0.8, using the
initial population HD minor allele frequency (MAF) of 0.29 and the TB MAF of 0.44, was of at
least 130 individuals in each population. The quantitative data was expressed as mean ± standard
error of the mean (SEM), and the Mann–Whitney U test or Analysis of variance (ANOVA) and the
Kruskal-Wallis post-test for unpaired and non-parametric samples were used to analyze differences
between groups. For categorical variables, the X2 test for homogeneity was performed to compare
proportions of subjects between groups. All statistical analysis were performed using GraphPad Prism
v7.0 or the R software [31]. p values of <0.05 were considered statistically significant.
3. Results
3.1. Demographic Characteristics of the Populations Studied
In order to investigate the association between the IFNG rs1861494 SNP and tuberculosis in
Argentina, 175 HD and 201 TB were recruited between 2014 and 2017. Demographic characteristics
of both populations are shown in Table 1. The populations under study are comparable in terms of
ethnicity and age but displayed different sex proportions.
Table 1. Demographic characteristics of healthy donors (HD) and tuberculosis (TB) populations.
HD TB p-value
N 175 201
Age (years) 34.25 ± 1.16 33.03 ± 0.98 0.123 a
Ethnicity Caucasian 65.3% 63.9% 0.896 bAmerican Indian 34.7% 36.1%
Sex
Male 36.6% 72.9%
<0.001 bFemale 63.4% 27.1%
Categorical variables are expressed in percentages. Age value is expressed as mean ± standard error of the mean
(SEM). a p-values were calculated by the Mann-Whitney U test for unpaired samples. b p-values were calculated by
X2 test for categorical variables. N: number of individuals.
Considering that these disparities could cause substantial problems for genetic association studies,
genotypic frequencies distribution of the IFNG rs1861494 SNP in HD and TB populations stratified
by ethnicity and sex were calculated (Table 2). Since no differences were found, we concluded that
dissimilarities between the percentages of individuals from each sex or ethnicity would not affect the
genotype distribution analyzed in each population.
Table 2. Genotypic frequencies distribution of the Interferon gamma (IFNG) rs1861494 SNP in HD and
TB populations stratified by ethnicity and sex.
rs1861494 Genotypes HD (N = 175) TB (N = 201)
GG GA AA GG GA AA
Ethnicity
Caucasian 9 (7.89%) 62 (54.39%) 43 (37.72%) 20 (15.63%) 59 (46.09%) 49 (38.28%)
American Indian 6 (9.84%) 30 (49.18%) 25 (40.98%) 17 (23.29%) 34 (46.58%) 22 (30.14%)
p-value 0.783 0.308
Sex
Male 7 (11.11%) 29 (46.03%) 27 (42.86%) 32 (22.07%) 71 (48.97%) 42 (28.96%)
Female 11 (9.82%) 48 (42.86%) 53 (47.32%) 8 (14.29%) 26 (46.43%) 22 (39.28%)
p-value 0.847 0.268
The Table shows the number of individuals and frequencies (in parentheses) in HD and TB for each subgroup.
p-values were calculated by the X2 test for categorical variables.
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3.2. The IFNG rs1861494 SNP as a Biomarker for Tuberculosis Protection in Argentina
Figure 1A shows the genotypic and allelic frequencies distributions that were found in HD and TB
populations. Importantly, both populations were in HW equilibrium. X2 test of homogeneity showed
that HD and TB populations were significantly different regarding the genotypic and allelic frequencies.
Both the A allele and the AA genotype were found in a lower proportion in TB population, suggesting
that these variants could be associated with tuberculosis protection (67.7% A allele frequency and
45.7% AA genotype frequency in HD population; vs. 56.0% A allele frequency and 31.8% AA genotype
frequency in TB population). In fact, OR were calculated to estimate the level of association between
the IFNG rs1861494 genotypes and tuberculosis disease by logistic regression after adjusting for
confounding variables (Figure 1B). By comparing the AA genotype against GG, the OR value was
of 0.235 (95% CI = 0.063–0.695; p-value = 0.012), indicating an association of the AA genotype with
tuberculosis resistance. Additionally, the OR value of 0.303 (95% CI = 0.082–0.882; p-value = 0.044)
obtained by comparing the AG genotype against the GG, indicated that this genotype could also
be associated with tuberculosis resistance. Besides, by comparing the AA genotype with the AG,
the OR value was of 0.776 (95% CI = 0.415–1.453, p-value = 0.427), showing no differences between
both genotypes and tuberculosis resistance. These results suggest that only one copy of the A allele
could be enough to confer protection against tuberculosis, in line with a dominant genetic model.
Actually, OR were calculated in the dominant and recessive models (Figure 1C), and an association
with tuberculosis resistance was found in the dominant model (OR = 0.270; 95% CI = 0.075–0.753;
p-value = 0.022). Taken together, these data demonstrate an association between the A allele and
the AA and AG genotypes with a reduced frequency of individuals suffering from tuberculosis,
suggesting a potential relationship between the A allele of the IFNG rs1861494 SNP and protection
against tuberculosis in Argentina.
In order to get further evidences that support the protective role of the A allele in developing
tuberculosis, IFNG levels in plasma and IFNG production by Mtb-Ag-stimulated PBMCs from
HD carrying the different genotypes of the IFNG rs1861494 SNP were determined by ELISA and
Flow Cytometry. As shown in Table 3, no differences were found in the IFNG plasmatic levels
measured among HD carrying the different genotypes of the IFNG rs1861494 SNP. Nevertheless,
Mtb-Ag-stimulated PBMCs from AA HD displayed the highest IFNG levels in culture supernatants
and also presented the greatest percentage of CD4+IFNG+ lymphocytes, as compared to GG HD
subjects. These data are in agreement with the protective role found for the A allele in developing
tuberculosis. Furthermore, our findings suggest that AA individuals present the lowest susceptibility
to tuberculosis disease probably because they generate a more effective immune response against the
bacteria, in comparison with GG carriers.
Table 3. Association between the IFNG rs1861494 single nucleotide polymorphism (SNP) genotypic
variants and IFNG production in the context of tuberculosis.
rs1861494 SNP Genotypes p-value
GG AG AA
HD (N = 21)
IFNG levels in plasma (pg/mL) 13.59 (±5.78) 9.44 (±1.64) 15.33 (±6.72) 0.797
IFNG levels in culture supernatants (pg/mL) 5185 (±1491) 14,195 (±3835) 20,989 (±5218) 0.034
% CD4+ T cells IFNG+ 9.06 (±2.08) 15.47 (±3.66) 20.44 (±2.48) 0.035
TB (N = 21)
IFNG levels in plasma (pg/mL) 67.27 (±59.21) 46.31 (±20.25) 170.5 (±68.92) 0.144
IFNG levels in culture supernatants (pg/mL) 6772 (±2750) 7575 (±2011) 15,066 (±4553) 0.357
% CD4+ T cells IFNG+ 7.91 (±1.38) 12.39 (±4.99) 15.97 (±4.29) 0.809
IFNG production was determined in plasma samples and cell lysate Mycobacterium tuberculosis H37Rv strain
(Mtb-Ag)-stimulated peripheral blood mononuclear cells (PBMC) from HD and TB carrying the different genotypes
of the rs1861494 SNP by ELISA and Flow Cytometry. Values are expressed as the Mean ± SEM. p-values were
calculated by Analysis of variance (ANOVA) and the Kruskal-Wallis post-test for unpaired and non-parametric
samples. % CD4+ T cells IFNG+: percentage of total CD4 positive T cells producing IFNG.
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Figure 1. Genotypic and allelic frequencies of the Interferon gamma (IFNG) rs1861494 single nucleotide
polymorphism (SNP) in healthy donors (HD) and tuberculosis patients (TB) populations in Argentina.
(A) Pie chart representing the genotypic and allelic distribution of the IFNG rs1861494 SNP in both
populations. The number of individuals of each population and the frequencies (in parentheses)
are detailed. p-values w re calculated by the X2 test of homogeneity. Both populations were in
Hardy-Weinberg (HW) quilibrium. (B) Odds atios (OR) calculation was us d to qua tify the
association between tuberculosis and the different genotypes. (C) Dominant and recessive genetic
models for the association between the ra1861494 SNP and TB. Odds Ratio were calculated by logistic
regression after adjusting for confounding variables (age/ethnicity/sex).
3.3. Lack of Association between the IFNG rs1861494 SNP and the Severity of the Disease
We next analyzed some immunological and clinical parameters in the TB population in order
to invest gate the potential association between the IFNG s1861494 SNP and the severity of the
disease. No differences were found in the plasmatic levels of IFNG, the produ t on of IFNG and the
proliferative response of Mtb-Ag-stimulated PBMCs in TB carrying the different genotypes variants
(Table 3). In addition, no differences between the polymorphism distribution and clinical parameters
of the disease severity (hematologic counts, Acid-Fast Bacilli (AFB) in sputum smear or radiological
lessons) were detected (Table 4). Therefore, no evidence relating the IFNG rs1861494 SNP with a higher
tuberculosis severity in the Argentinean population was found.
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Table 4. Association between the IFNG rs1861494 SNP genotypic variants and some clinical parameters.
rs1861494 SNP Genotypes p-value
GG AG AA
Hematologic Studies (N = 105)
Leucocytes (cells/mL) 10,754 (±1557) 10,205 (±388.8) 9929 (±702.1) 0.432 a
Lymphocytes (cells/mL) 1964 (±349.5) 1491 (±76.45) 1573 (±126.5) 0.762 a
Monocytes (cells/mL) 1013 (±138.0) 809.3 (±58.38) 878.6 (±83.13) 0.584 a
Neutrophils (cells/mL) 8097 (±1557) 7524 (±586.6) 5674 (±574.4) 0.089 a
AFB in sputum smear (N = 150)
BAAR− or BAAR+ 14 (18.0%) 43 (55.1%) 21 (26.9%)
0.415 bBAAR++ or BAAR+++ 17 (23.6%) 32 (44.4%) 23 (32.0%)
Radiological Lesions (N = 136)
Mild or Moderate 11 (21.1%) 29 (55.8%) 12 (23.1%)
0.367 bSevere 17 (20.3%) 39 (46.4%) 28 (33.3%)
Months of disease progression (N = 105) 2.15 (±0.29) 2.92 (±3.56) 2.29 (±0.35) 0.447 a
Hematologic studies representing the leukocyte, lymphocyte, monocyte and neutrophil counts in peripheral blood
are shown. Acid-Fast Bacilli (AFB) in sputum smear represent: BAAR−: 0 bacilli count; BAAR+: 1–9 bacilli/100
fields; BAAR++: 1–9 bacilli/10 fields; BAAR+++: 1–9 bacilli/field. Radiological lesions: mild corresponds to
patients with a single lobe involved and without visible cavities; moderate relates to patients presenting unilateral
involvement of two or more lobes with cavities, if present, reaching a total diameter no greater than 4 cm; severe
corresponds to bilateral disease with massive affectation and multiple cavities. Clinical symptoms analyzed in
TB previous to hospital admission to establish the time (months) of disease progression were: weight loss, night
sweats, symptoms of malaise or weakness, persistent fever, presence of cough, history of shortness of breath,
and hemoptysis. Continuous data are expressed as the Mean ±SEM, and categorical data are expressed as number
(percentages of genotype). a p-values were calculated by the Kruskal-Wallis (ANOVA) test for unpaired and
non-parametric samples. b p-values were calculated by the X2 test for categorical variables.
4. Discussion
To date, only two reports in the Argentinean population have analyzed the association between
a cytokine SNP and tuberculosis, but no one in the IFNG gene, a crucial cytokine for controlling
Mtb infection [27,32]. Here, by using a case-control study, we reported an association between
the AA and AG genotype of the IFNG rs1861494 SNP with tuberculosis resistance in Argentina,
indicating that only one copy of the A allele is enough to confer protection against the disease in
our population. In particular, the IFNG rs1861494 SNP was a good candidate to study the genetic
association because it has been widely validated (sequenced in 1000 Genome project, Genotyped by
HapMap project, and multiple, independent submissions to the ref SNP cluster) [33] and associated
with different diseases immunoglobulin A (IgA) nephropathy, vitiligo, inflammatory bowel disease,
leprosy, tuberculosis, between others) [28,34–37].
Other studies have investigated the association between IFNG rs1861494 SNP and tuberculosis
risk, but inconsistent results were found [37–41]. In contrast to our present findings, the A allele
was reported to be related to tuberculosis susceptibility in an Indian population [38]. Also, another
study from Taiwan found that AA and AG carriers were risky genotypes regarding susceptibility to
tuberculosis [39]. Besides, one report from Croatia and another from China evidenced no association
between the SNP and the disease [40,41]. Nevertheless, our results are in agreement with a study
performed in Iran, a population ethnically different from ours, further supporting the fact of a higher
resistance to tuberculosis disease in individuals carrying the A allele of the IFNG rs1861494 SNP [37].
These discrepancies might be related to differences in the selection of the control group, ethnic
differences or lack of HW equilibrium in the population analyzed.
Ethnicity and sex could be confounding variables in genetic association analyses. Both populations
under study in the present work were comparable in terms of ethnic composition but displayed
different sex proportions. Importantly, these ethnic frequencies were quite similar to the ethnic
composition of the Argentinean population [42,43]. Remarkably, no differences were found in the
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genotypic frequencies distribution of the IFNG rs1861494 SNP in HD and TB population stratified by
ethnicity and sex. Additionally, the genotypes distribution in the HD and TB populations showed no
deviation from HW equilibrium, indicating that there is a population substructure. Also, the logistic
regression used to evaluate the association between the IFNG rs1861494 SNP and tuberculosis disease
was adjusted for age, ethnicity and sex. For all the mentioned reasons, it is unlikely that the ethnicity
and sex act as confounding variables in these genetic association analyses.
It was evidenced that the rs1861494 SNP might have a functional consequence on IFNG
expression, as a result of an introduction of a new potential CpG methylation site that altered
the binding of transcription factors (Nuclear factor of activated T-cells (NFAT), nuclear factor
kappa-light-chain-enhancer of activated B cells (NFκB)) to this region. In fact, it was reported the
association of the A allele with higher levels of IFNG [28,29]. We did not find any differences in
the plasmatic IFNG among individuals carrying the different genotypes of the IFNG rs1861494 SNP,
but we did demonstrate that Mtb-Ag-stimulated PBMCs from AA HD displayed the highest IFNG
levels in culture supernatants and also showed the greatest percentage of CD4+IFNG+ lymphocytes,
in comparison with GG carriers. These data reinforce the idea that AA HD may present the lowest
susceptibility to tuberculosis disease by producing the highest levels of IFNG, that may contribute
to eliminate the pathogen at a first contact. In contrast to the results obtained in the case-control
study, no differences were found between the IFNG production by Mtb-Ag-stimulated PBMCs from
HD carrying the AG or GG genotype. These data suggest that there would be no differences in the
immune response against Mtb in HD carrying those genotypes, although a trend to a higher IFNG
production was observed in individuals carrying the AG genotype. Studies with a larger sample size,
using stimulated pleural fluid mononuclear cells or Mtb-specific antigens as stimuli could help to
clarify this point.
To our knowledge, this is the first study that evaluates the IFNG production by PBMC stimulated
with Mtb-Ag from individuals carrying the different genotypes of the IFNG rs1861494 SNP. However,
no differences in IFNG production by Mtb-Ag-stimulated PBMCs were detected in TB carrying the
different genotypes variants. Yet, we have previously shown that Mtb-infection status is related to
a decrease in IFNG production in TB as compared to HD [44,45], probably due to different evasion
strategies of the mycobacteria [46]. Especially, it was demonstrated that NFAT plays a critical role in
immune containment of tuberculosis disease in vivo and that T cell terminal signaling events, like
NFAT and NFκB binding, are altered by Mtb antigens, an evasion mechanism that could be involved
in T-cell impaired functions during the progression of the disease [47]. These alterations could explain
the lack of association between the IFNG rs1861494 SNP genotype and IFNG production in TB. Further
studies are required to confirm this hypothesis. We also investigated relevant tuberculosis clinical
parameters in the different genotypes to analyze whether they could be related to disease severity.
However, no differences were found in the hematologic counts, the number of AFB in sputum smear
or in the radiological lesions, as previously reported [40].
The possible involvement of another functional polymorphism in strong linkage disequilibrium
(LD) with the IFNG rs1861494 polymorphism cannot be ruled out. In particular, the rs1861493 SNP
(T/C) on the IFNG gene has been described to be in LD with rs1861494 SNP, and it is associated
with some diseases, like Kawasaki Disease, in which IFNG production plays an important role in its
immunopathogenesis [48,49]. Besides, IFNG rs1861493 SNP and rs1861494 SNP were associated with
susceptibility to pulmonary tuberculosis, but the contribution of each one was not clarified [38].
We cannot exclude the possibility of linkage disequilibrium between the IFNG rs1861494 SNP
variants and other neighboring polymorphisms without additional fine-mapping analysis of SNPs
throughout the region. Nevertheless, the functional mechanism of the IFNG rs1861494 SNP, altering
transcription factors binding in a regulatory region of the IFNG gene, emphasizes the importance of
this polymorphism. However, due to the weak effect of a single genetic polymorphism, other genes in
the immunity pathway, together with environmental factors, should also be considered.
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Overall, this is the first report demonstrating that the IFNG rs1861494 SNP is related to tuberculosis
resistance in the Argentinean population, with no association with the disease severity. Also,
we evidenced that Mtb-Ag stimulated PBMCs from HD carrying the AA genotype produce significant
higher levels of IFNG in comparison with GG carriers. Therefore, our data suggest that the A allele of
the IFNG rs1861494 SNP could be considered as a biomarker for tuberculosis resistance in Argentina.
Supplementary Materials: The following are available online at www.mdpi.com/2073-4425/9/1/46/s1.
Supplementary Figure S1: IFNG rs1861494 SNP genotyping by ARMS-PCR method.
Acknowledgments: We thank Virginia Pasquinelli, Guadalupe I. Alvarez and Rodrigo E. Hernandez Del Pino
for continuous support. We also thank Sergio I. Nemirovsky and Juan C. Vilardi for expert technical assistance.
This work was supported by grants from ANPCyT (PICT-1762 and PICT-0611 to V.E.G.); UBA (20020130100236BA
to V.E.G., 20020150200107BA to N.O.A.); and Fundación Roemmers (FAJR 2016-17 to AR). A.R., J.M.P., M.P.M. and
F.A.C. are fellows of Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET). N.O.A., N.L.T. and
V.E.G. are members of the Researcher Career of CONICET. The authors have no financial conflicts of interests.
Author Contributions: V.E.G. and A.R. conceived and designed the experiments; N.C., A.L. and D.J.P. were
in charge of patient recruitment, diagnosis of active tuberculosis and sample collection; A.R., J.M.P., N.O.A.,
M.P.M., F.A.C. and N.L.T. were responsible for processing samples and performing ELISA and flow cytometry
analysis; A.R. and M.C.S. were in charge of DNA extraction and genotyping; A.R. and V.E.G. performed the data
management and analysis; A.R. and V.E.G. wrote the manuscript. All authors contributed to data gathering and
interpretation, and revision of the report. Each author has approved the submitted version.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. World Health Organization. Global Tuberculosis Report. 2016. Available online: http://apps.who.int/iris/
bitstream/10665/250441/1/9789241565394-eng.pdf?ua=1 (accessed on 20 October 2017).
2. Administración Nacional de Laboratorios e Institutos de Salud (ANLIS). Notificación de Casos de Tuberculosis
en la República Argentina. Available online: http://www.anlis.gov.ar/iner/wp-content/uploads/2016/
11/Notificacion-de-casos-de-Tuberculosis-en-la-Republica-Argentina-Periodo-1980-2015.pdf (accessed on
20 October 2017).
3. Fortin, A.; Abel, L.; Casanova, J.L.; Gros, P. Host genetics of mycobacterial diseases in mice and men: Forward
genetic studies of BCG-osis and tuberculosis. Annu. Rev. Genom. Hum. Genet. 2007, 8, 163–192. [CrossRef]
[PubMed]
4. Philips, J.A.; Ernst, J.D. Tuberculosis pathogenesis and immunity. Annu. Rev. Pathol. 2012, 7, 353–384.
[CrossRef] [PubMed]
5. Jasenosky, L.D.; Scriba, T.J.; Hanekom, W.A.; Goldfeld, A.E. T cells and adaptive immunity to
Mycobacterium tuberculosis in humans. Immunol. Rev. 2015, 264, 74–87. [CrossRef] [PubMed]
6. Flynn, J.L.; Chan, J.; Triebold, K.J.; Dalton, D.K.; Stewart, T.A.; Bloom, B.R. An essential role for interferon
gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 1993, 178, 2249–2254. [CrossRef]
[PubMed]
7. Cooper, A.M.; Dalton, D.K.; Stewart, T.A.; Griffin, J.P.; Russell, D.G.; Orme, I.M. Disseminated tuberculosis
in interferon gamma gene-disrupted mice. J. Exp. Med. 1993, 178, 2243–2247. [CrossRef] [PubMed]
8. Chan, J.; Xing, Y.; Magliozzo, R.S.; Bloom, B.R. Killing of virulent Mycobacterium tuberculosis by reactive
nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 1992, 175, 1111–1122.
[CrossRef] [PubMed]
9. MacMicking, J.D.; Taylor, G.A.; McKinney, J.D. Immune control of tuberculosis by IFN-γ-inducible LRG-47.
Science 2003, 302, 654–659. [CrossRef] [PubMed]
10. Rovetta, A.I.; Pena, D.; Hernandez Del Pino, R.E.; Recalde, G.M.; Pellegrini, J.; Bigi, F.; Musella, R.M.;
Palmero, D.J.; Gutierrez, M.; Colombo, M.I.; et al. IFNG-mediated immune responses enhance autophagy
against Mycobacterium tuberculosis antigens in patients with active tuberculosis. Autophagy 2014, 10, 2109–2121.
[CrossRef] [PubMed]
11. Fabri, M.; Stenger, S.; Shin, D.M.; Yuk, J.M.; Liu, P.T.; Realegeno, S.; Lee, H.M.; Krutzik, S.R.; Schenk, M.;
Sieling, P.A.; et al. Vitamin D is required for IFN-γ-mediated antimicrobial activity of human macrophages.
Sci. Transl. Med. 2011, 3, 104ra102. [CrossRef] [PubMed]
Genes 2018, 9, 46 10 of 12
12. Sodhi, A.; Gong, J.; Silva, C.; Qian, D.; Barnes, P.F. Clinical correlates of interferon gamma production in
patients with tuberculosis. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 1997, 25, 617–620. [CrossRef]
13. Pasquinelli, V.; Quiroga, M.F.; Martinez, G.J.; Zorrilla, L.C.; Musella, R.M.; Bracco, M.M.; Belmonte, L.;
Malbran, A.; Fainboim, L.; Sieling, P.A.; et al. Expression of signaling lymphocytic activation molecule-associated
protein interrupts IFN-γ production in human tuberculosis. J. Immunol. 2004, 172, 1177–1185. [CrossRef]
[PubMed]
14. Thillai, M.; Pollock, K.; Pareek, M.; Lalvani, A. Interferon-γ release assays for tuberculosis: Current and
future applications. Expert Rev. Respir. Med. 2014, 8, 67–78. [CrossRef] [PubMed]
15. Pacheco, A.G.; Moraes, M.O. Genetic polymorphisms of infectious diseases in case-control studies. Dis. Mark.
2009, 27, 173–186. [CrossRef] [PubMed]
16. Bustamante, J.; Boisson-Dupuis, S.; Abel, L.; Casanova, J.L. Mendelian susceptibility to mycobacterial disease:
Genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. Semin. Immunol. 2014, 26,
454–470. [CrossRef] [PubMed]
17. Hyvarinen, K.; Ritari, J.; Koskela, S.; Niittyvuopio, R.; Nihtinen, A.; Volin, L.; Gallardo, D.; Partanen, J.
Genetic polymorphism related to monocyte-macrophage function is associated with graft-versus-host
disease. Sci. Rep. 2017, 7, 15666. [CrossRef] [PubMed]
18. Abana, C.O.; Bingham, B.S.; Cho, J.H.; Graves, A.J.; Koyama, T.; Pilarski, R.T.; Chakravarthy, A.B.; Xia, F.
IL-6 variant is associated with metastasis in breast cancer patients. PLoS ONE 2017, 12, e0181725. [CrossRef]
[PubMed]
19. Lemos, N.E.; Dieter, C.; Dorfman, L.E.; Assmann, T.S.; Duarte, G.C.K.; Canani, L.H.; Bauer, A.C.; Crispim, D.
The rs2292239 polymorphism in ERBB3 gene is associated with risk for type 1 diabetes mellitus in a Brazilian
population. Gene 2017. [CrossRef] [PubMed]
20. Manolova, I.; Miteva, L.; Ivanova, M.; Kundurzhiev, T.; Stoilov, R.; Stanilova, S. The synergistic effect of TNFα
and IL10 promoter polymorphisms on genetic predisposition to systemic Lupus erythematosus. Genet. Test.
Mol. Biomark. 2018. [CrossRef] [PubMed]
21. Czepiel, J.; Biesiada, G.; Drozdz, M.; Gdula-Argasinska, J.; Zuranska, J.; Marchewka, J.; Perucki, W.;
Wolkow, P.; Garlicki, A. The presence of IL-8 +781 T/C polymorphism is associated with the parameters of
severe Clostridium difficile infection. Microb. Pathog. 2017, 114, 281–285. [CrossRef] [PubMed]
22. Talaat, R.M.; Abdelkhalek, M.S.; El-Maadawy, E.A.; Abdel-Mageed, W.S.; El-Shenawy, S.Z.; Osman, M.A.
Association of TNF-Alpha gene polymorphisms and susceptibility to hepatitis B virus infection in Egyptians.
Hum. Immunol. 2017, 78, 739–746. [CrossRef] [PubMed]
23. Zhang, G.; Zhou, B.; Wang, W.; Zhang, M.; Zhao, Y.; Wang, Z.; Yang, L.; Zhai, J.; Feng, C.G.; Wang, J.; et al.
A functional single-nucleotide polymorphism in the promoter of the gene encoding interleukin 6 is associated
with susceptibility to tuberculosis. J. Infect. Dis. 2012, 205, 1697–1704. [CrossRef] [PubMed]
24. Mao, X.; Ke, Z.; Liu, S.; Tang, B.; Wang, J.; Huang, H.; Chen, S. IL-1β+3953C/T, -511T/C and IL-6 -174C/G
polymorphisms in association with tuberculosis susceptibility: A meta-analysis. Gene 2015, 573, 75–83.
[CrossRef] [PubMed]
25. Liu, G.; Li, G.; Xu, Y.; Song, N.; Shen, S.; Jiang, D.; Zeng, W.; Wang, H. Association between IL12B
polymorphisms and tuberculosis risk: A meta-analysis. Infect. Genet. Evol. J. Mol. Epidemiol. Evolut. Genet.
Infect. Dis. 2014, 21, 401–407. [CrossRef] [PubMed]
26. Pacheco, A.G.; Cardoso, C.C.; Moraes, M.O. IFNG +874T/A, IL10 -1082G/A and TNF -308G/A
polymorphisms in association with tuberculosis susceptibility: A meta-analysis study. Hum. Genet. 2008,
123, 477–484. [CrossRef] [PubMed]
27. Rolandelli, A.; Hernandez Del Pino, R.E.; Pellegrini, J.M.; Tateosian, N.L.; Amiano, N.O.; de la Barrera, S.;
Casco, N.; Gutierrez, M.; Palmero, D.J.; Garcia, V.E. The IL-17A rs2275913 single nucleotide polymorphism is
associated with protection to tuberculosis but related to higher disease severity in Argentina. Sci. Rep. 2017,
7, 40666. [CrossRef] [PubMed]
28. Gonsky, R.; Deem, R.L.; Landers, C.J.; Haritunians, T.; Yang, S.; Targan, S.R. IFNG rs1861494 polymorphism is
associated with IBD disease severity and functional changes in both IFNG methylation and protein secretion.
Inflamm. Bowel Dis. 2014, 20, 1794–1801. [CrossRef] [PubMed]
Genes 2018, 9, 46 11 of 12
29. Peresi, E.; Oliveira, L.R.; da Silva, W.L.; da Costa, E.A.; Araujo, J.P., Jr.; Ayres, J.A.; Fortes, M.R.; Graviss, E.A.;
Pereira, A.C.; Calvi, S.A. Cytokine polymorphisms, their influence and levels in Brazilian patients with
pulmonary tuberculosis during antituberculosis treatment. Tuberc. Res. Treat. 2013, 2013, 285094. [CrossRef]
[PubMed]
30. Little, S. Amplification-refractory mutation system (ARMS) analysis of point mutations. Curr. Protoc.
Hum. Genet. 2001, 9, 9.8.1–9.8.12.
31. R Development Core Team. R: A Language and Environment for Statistical Computing. Available online:
http://www.R-project.org (accessed on 20 October 2017).
32. Morris, G.A.; Edwards, D.R.; Hill, P.C.; Wejse, C.; Bisseye, C.; Olesen, R.; Edwards, T.L.; Gilbert, J.R.;
Myers, J.L.; Stryjewski, M.E.; et al. Interleukin 12b (IL12B) genetic variation and pulmonary tuberculosis:
A study of cohorts from the Gambia, Guinea-Bissau, United States and Argentina. PLoS ONE 2011, 6, e16656.
[CrossRef]
33. NIH. dbSNP Short Genetic Variations. Available online: https://www.ncbi.nlm.nih.gov/projects/SNP/
(accessed on 20 October 2017).
34. Gao, J.; Wei, L.; Liu, X.; Wang, L.; Niu, D.; Jin, T.; Yao, G.; Wang, M.; Yu, Q.; Fu, R. Association between IFN-γ
gene polymorphisms and IgA nephropathy in a Chinese Han population. Kidney Blood Press. Res. 2017, 42,
136–144. [CrossRef] [PubMed]
35. Karam, R.; Essam, H.; Khater, M. Genetic variants of INF-gamma and its mRNA expression and inflammatory
parameters in vitiligo pathogenesis. Biochem. Cell Biol. 2017, 95, 474–481. [CrossRef] [PubMed]
36. Cardoso, C.C.; Pereira, A.C.; Brito-de-Souza, V.N.; Dias-Baptista, I.M.; Maniero, V.C.; Venturini, J.;
Vilani-Moreno, F.R.; de Souza, F.C.; Ribeiro-Alves, M.; Sarno, E.N.; et al. IFNG +874 T>A single nucleotide
polymorphism is associated with leprosy among Brazilians. Hum. Genet. 2010, 128, 481–490. [CrossRef]
[PubMed]
37. Varahram, M.; Farnia, P.; Nasiri, M.J.; Karahrudi, M.A.; Dizagie, M.K.; Velayati, A.A. Association
of Mycobacterium tuberculosis lineages with IFN-γ and TNF-α gene polymorphisms among pulmonary
tuberculosis patient. Mediterr. J. Hematol. Infect. Dis. 2014, 6, e2014015. [CrossRef] [PubMed]
38. Abhimanyu, M.B.; Jha, P. Indian Genome Variation Consortium. Footprints of genetic susceptibility to
pulmonary tuberculosis: Cytokine gene variants in north Indians. Indian J. Med. Res. 2012, 135, 763–770.
39. Lee, S.W.; Chuang, T.Y.; Huang, H.H.; Lee, K.F.; Chen, T.T.; Kao, Y.H.; Wu, L.S. Interferon gamma
polymorphisms associated with susceptibility to tuberculosis in a Han Taiwanese population. J. Microbiol.
Immunol. Infect. 2015, 48, 376–380. [CrossRef] [PubMed]
40. Etokebe, G.E.; Bulat-Kardum, L.; Johansen, M.S.; Knezevic, J.; Balen, S.; Matakovic-Mileusnic, N.; Matanic, D.;
Flego, V.; Pavelic, J.; Beg-Zec, Z.; et al. Interferon-γ gene (T874A and G2109A) polymorphisms are associated
with microscopy-positive tuberculosis. Scand. J. Immunol. 2006, 63, 136–141. [CrossRef] [PubMed]
41. Yang, Y.; Li, X.; Cui, W.; Guan, L.; Shen, F.; Xu, J.; Zhou, F.; Li, M.; Gao, C.; Jin, Q.; et al. Potential association
of pulmonary tuberculosis with genetic polymorphisms of toll-like receptor 9 and interferon-γ in a chinese
population. BMC Infect. Dis. 2013, 13, 511. [CrossRef] [PubMed]
42. Avena, S.; Via, M.; Ziv, E.; Perez-Stable, E.J.; Gignoux, C.R.; Dejean, C.; Huntsman, S.; Torres-Mejia, G.;
Dutil, J.; Matta, J.L.; et al. Heterogeneity in genetic admixture across different regions of Argentina. PLoS ONE
2012, 7, e34695. [CrossRef] [PubMed]
43. Homburger, J.R.; Moreno-Estrada, A.; Gignoux, C.R.; Nelson, D.; Sanchez, E.; Ortiz-Tello, P.; Pons-Estel, B.A.;
Acevedo-Vasquez, E.; Miranda, P.; Langefeld, C.D.; et al. Genomic insights into the ancestry and demographic
history of south America. PLoS Genet. 2015, 11, e1005602. [CrossRef] [PubMed]
44. Pasquinelli, V.; Rovetta, A.I.; Alvarez, I.B.; Jurado, J.O.; Musella, R.M.; Palmero, D.J.; Malbran, A.; Samten, B.;
Barnes, P.F.; Garcia, V.E. Phosphorylation of mitogen-activated protein kinases contributes to interferon
gamma production in response to Mycobacterium tuberculosis. J. Infect. Dis. 2013, 207, 340–350. [CrossRef]
[PubMed]
45. Jurado, J.O.; Pasquinelli, V.; Alvarez, I.B.; Pena, D.; Rovetta, A.I.; Tateosian, N.L.; Romeo, H.E.; Musella, R.M.;
Palmero, D.; Chuluyan, H.E.; et al. IL-17 and IFN-γ expression in lymphocytes from patients with active
tuberculosis correlates with the severity of the disease. J. Leukoc. Biol. 2012, 91, 991–1002. [CrossRef]
[PubMed]
Genes 2018, 9, 46 12 of 12
46. Wang, X.; Barnes, P.F.; Dobos-Elder, K.M.; Townsend, J.C.; Chung, Y.T.; Shams, H.; Weis, S.E.; Samten, B.
Esat-6 inhibits production of IFN-γ by Mycobacterium tuberculosis-responsive human T cells. J. Immunol. 2009,
182, 3668–3677. [CrossRef] [PubMed]
47. Via, L.E.; Tsytsykova, A.V.; Rajsbaum, R.; Falvo, J.V.; Goldfeld, A.E. The transcription factor NFATp plays a
key role in susceptibility to TB in mice. PLoS ONE 2012, 7, e41427. [CrossRef] [PubMed]
48. Kumar, A.; Ghosh, B. A single nucleotide polymorphism (A –> G) in intron 3 of IFNγ gene is associated with
asthma. Genes Immun. 2008, 9, 294–301. [CrossRef] [PubMed]
49. Huang, Y.H.; Hsu, Y.W.; Lu, H.F.; Wong, H.S.; Yu, H.R.; Kuo, H.C.; Huang, F.C.; Chang, W.C.; Kuo, H.C.
Interferon-gamma genetic polymorphism and expression in Kawasaki disease. Medicine 2016, 95, e3501.
[CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
